ALPS’ Industry Partners

American Limb Preservation Society

We are very proud to present our industry partners here

Founding Partner

SANUWAVE’s end-to-end wound care approach of non-invasive regenerative technology helps restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac/endovascular conditions. The combination of SANUWAVE’s dermaPACE® System and the UltraMIST® System is the basis for its “Energy First” protocol for wound healing that add to the solutions that improve clinical outcomes across the continuum of wound care.

Please visit our website

Platinum Partner

Advanced Oxygen Therapy Inc. (AOTI) provides a unique cyclical-pressurized Topical Wound Oxygen (TWO2) therapy that’s RCT & RWE proven to heal chronic wounds more durably, resulting in significant reductions in hospitalizations and amputations. TWO2 is a multi-modality homecare approach that combines higher pressure oxygen delivery, with cyclical non-contact compression and humidification. TWO2, Proven to Deliver Sustained Wound Healing and Preventing Amputations, So Life Can Get Back to Normal…

Visit AOTI at and learn more

Silver Partners

As a leader in nutrition science, research and development, Abbott’s goal is to deliver nutrition products and education that meet the changing needs of families across the world. We make products to help babies and children grow, that work to keep bodies strong, and that support the unique nutritional and therapeutic needs of adults. This includes Juven, a nutritional drink mix to help support wound healing in various wound types including diabetic foot ulcers, vascular ulcers, pressure injuries and surgical wounds.

Nutrition is the foundation to healthy living and here at Abbott Nutrition, we provide resources to help people live their best life. Learn more at Learn more about Juven for wound healing at

Nevro is a medical device company based in Redwood City, CA that has the simple goal of helping more patients suffering from chronic pain achieve lasting relief. On 7/16/21, Nevro became the only spinal cord stimulation (SCS) company to receive FDA approval for an expanded indication for its Senza SCS System to treat patients with pain of the lower limbs associated with diabetic neuropathy. Nevro conducted the largest RCT to date, studying SCS in patients with diabetic neuropathy.

For more information visit or

If your company would like to become ALPS’ next Industry Partner, contact us at [email protected]